{"altmetric_id":4892305,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":14},"news":{"unique_users_count":1,"unique_users":["medscape"],"posts_count":1},"twitter":{"unique_users_count":8,"unique_users":["JAMAOnc","mlazqui","Intl_Nurses","JAMANetwork","iahcp","LotteSteuten","analeoca66","weldeiry"],"posts_count":10},"facebook":{"unique_users_count":1,"unique_users":["759822190741773"],"posts_count":2},"googleplus":{"unique_users_count":1,"unique_users":["JAMA Oncology"],"posts_count":1}},"citation":{"altmetric_jid":"54d8989b2a83eea31c8b4567","authors":["Henry T. Lynch","Brody Slostad","Peter Silberstein"],"doi":"10.1001\/jamaoncol.2015.4653","first_seen_on":"2015-12-18T06:32:29+00:00","funders":["niehs"],"issns":["2374-2445","2374-2437"],"issue":"3","journal":"JAMA Oncology","last_mentioned_on":1457922786,"links":["http:\/\/oncology.jamanetwork.com\/article.aspx?articleID=2475478&utm_source=twitter&utm_medium=social_jamaonc&utm_campaign=article_alert&utm_content=automated","http:\/\/oncology.jamanetwork.com\/article.aspx?articleid=2475478&utm_source=twitter&utm_medium=social_jamaonc&utm_campaign=article_alert&utm_content=automated#.VnOrsNf3rXE.twitter","http:\/\/oncology.jamanetwork.com\/article.aspx?articleID=2475478&utm_source=facebook&utm_medium=social_jamaonc&utm_campaign=article_alert&utm_content=automated","http:\/\/dx.doi.org\/10.1001\/jamaoncol.2015.4653","http:\/\/oncology.jamanetwork.com\/article.aspx?articleID=2475478&utm_source=gplus&utm_medium=social_jamaonc&utm_campaign=article_alert&utm_content=automated","http:\/\/oncology.jamanetwork.com\/article.aspx?articleID=2475478&utm_source=dlvr.it&utm_medium=%5Btwitter%5D&utm_campaign=%5Barticle_alert%5D&utm_content=%5Bautomated%5D"],"pdf_url":"http:\/\/oncology.jamanetwork.com\/data\/Journals\/ONCOLOGY\/0\/cic150045.pdf","pmid":"26720158","pubdate":"2015-12-17T00:00:00+00:00","title":"Familial Carcinoma of Unknown Primary","type":"article","volume":"2"},"altmetric_score":{"score":13.85,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":13.85},"context_for_score":{"all":{"total_number_of_other_articles":7391940,"mean":6.4229753378604,"rank":505838,"this_scored_higher_than_pct":93,"this_scored_higher_than":6884582,"rank_type":"exact","sample_size":7391940,"percentile":93},"similar_age_3m":{"total_number_of_other_articles":298653,"mean":8.9310026519157,"rank":28234,"this_scored_higher_than_pct":90,"this_scored_higher_than":270346,"rank_type":"exact","sample_size":298653,"percentile":90},"this_journal":{"total_number_of_other_articles":844,"mean":83.019172004745,"rank":587,"this_scored_higher_than_pct":30,"this_scored_higher_than":256,"rank_type":"exact","sample_size":844,"percentile":30},"similar_age_this_journal_3m":{"total_number_of_other_articles":105,"mean":57.874653846154,"rank":73,"this_scored_higher_than_pct":29,"this_scored_higher_than":31,"rank_type":"exact","sample_size":105,"percentile":29}}},"demographics":{"poster_types":{"member_of_the_public":4,"researcher":1,"practitioner":2,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":4,"Practitioners (doctors, other healthcare professionals)":2,"Science communicators (journalists, bloggers, editors)":1,"Scientists":1}}},"geo":{"twitter":{"ES":1,"US":3}}},"posts":{"news":[{"title":"Cancer of Unknown Primary Increases Cancer Risks","url":"http:\/\/ct.moreover.com\/?a=23904145901&p=1pl&v=1&x=Xl8LMxq-7hg8nYOTJuQWXg","license":"public","citation_ids":[4892305],"posted_on":"2015-12-28T15:54:16+00:00","summary":"Reuters Health Information By Laura Newman | December 28, 2015 NEW YORK (Reuters) - First-degree relatives of people with cancer of unknown primary are at greater risk for cancer of an unknown primary, as well as cancers of the lung, pancreas, and\u2026","author":{"name":"Medscape","url":"http:\/\/medscape.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/055\/normal\/medscape.png?1369846939"}}],"twitter":[{"url":"http:\/\/twitter.com\/JAMAOnc\/statuses\/677737868559708160","license":"gnip","citation_ids":[4892305],"posted_on":"2015-12-18T06:31:14+00:00","author":{"name":"JAMA Oncology","image":"https:\/\/pbs.twimg.com\/profile_images\/512275426798882816\/piK2tIt6_normal.png","id_on_source":"JAMAOnc","tweeter_id":"2811548749","geo":{"lt":null,"ln":null},"followers":11174},"tweet_id":"677737868559708160"},{"url":"http:\/\/twitter.com\/mlazqui\/statuses\/677741554308669442","license":"gnip","citation_ids":[4892305],"posted_on":"2015-12-18T06:45:53+00:00","author":{"name":"Mart\u00edn L\u00e1zaro","url":"http:\/\/www.novedadesenoncologia.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000653691864\/11d6fb0c77217bfce2c907aa9b0f2ee5_normal.jpeg","description":"Medical oncologist. Lung and genitourinary cancer.","id_on_source":"mlazqui","tweeter_id":"196132848","geo":{"lt":42.23282,"ln":-8.72264,"country":"ES"},"followers":1669},"tweet_id":"677741554308669442"},{"url":"http:\/\/twitter.com\/Intl_Nurses\/statuses\/677744778923110400","license":"gnip","rt":["JAMAOnc"],"citation_ids":[4892305],"posted_on":"2015-12-18T06:58:41+00:00","author":{"name":"International Nurses","url":"http:\/\/www.INAnurse.com","image":"https:\/\/pbs.twimg.com\/profile_images\/484380568516173825\/q34qInLn_normal.jpeg","description":"As the fastest-growing publisher of medical professional biographies we deliver the recognition and competitive edge needed for success.","id_on_source":"Intl_Nurses","tweeter_id":"633006932","geo":{"lt":40.72982,"ln":-73.21039,"country":"US"},"followers":6109},"tweet_id":"677744778923110400"},{"url":"http:\/\/twitter.com\/JAMANetwork\/statuses\/707973053662121984","license":"gnip","citation_ids":[4892305],"posted_on":"2016-03-10T16:55:04+00:00","author":{"name":"The JAMA Network","image":"https:\/\/pbs.twimg.com\/profile_images\/2151337984\/jamanetwork3_normal.png","id_on_source":"JAMANetwork","tweeter_id":"404920570","geo":{"lt":null,"ln":null},"followers":405},"tweet_id":"707973053662121984"},{"url":"http:\/\/twitter.com\/Intl_Nurses\/statuses\/708903471181897728","license":"gnip","rt":["JAMAOnc"],"citation_ids":[4892305],"posted_on":"2016-03-13T06:32:12+00:00","author":{"name":"International Nurses","url":"http:\/\/www.INAnurse.com","image":"https:\/\/pbs.twimg.com\/profile_images\/484380568516173825\/q34qInLn_normal.jpeg","description":"As the fastest-growing publisher of medical professional biographies we deliver the recognition and competitive edge needed for success.","id_on_source":"Intl_Nurses","tweeter_id":"633006932","geo":{"lt":40.72982,"ln":-73.21039,"country":"US"},"followers":6109},"tweet_id":"708903471181897728"},{"url":"http:\/\/twitter.com\/iahcp\/statuses\/708903472473763840","license":"gnip","rt":["JAMAOnc"],"citation_ids":[4892305],"posted_on":"2016-03-13T06:32:13+00:00","author":{"name":"IAHCP","url":"http:\/\/IAHCP.com","image":"https:\/\/pbs.twimg.com\/profile_images\/519959351964876800\/YZIsvxSg_normal.png","description":"Managing Editor for International Association of HealthCare Professionals (IAHCP), my goal is to implement ideas that lead to growth across multimedia platforms","id_on_source":"iahcp","tweeter_id":"1160413512","geo":{"lt":40.72982,"ln":-73.21039,"country":"US"},"followers":5490},"tweet_id":"708903472473763840"},{"url":"http:\/\/twitter.com\/LotteSteuten\/statuses\/708904589571952640","license":"gnip","rt":["JAMAOnc"],"citation_ids":[4892305],"posted_on":"2016-03-13T06:36:39+00:00","author":{"name":"Lotte Steuten","image":"https:\/\/pbs.twimg.com\/profile_images\/639539600248037376\/7zOeP5_4_normal.jpg","description":"Health Economist by day; Triathlete by night. Sceptic of anything gluten-free or all-male. Tweets may get personal.","id_on_source":"LotteSteuten","tweeter_id":"874080517","geo":{"lt":47.60621,"ln":-122.33207,"country":"US"},"followers":513},"tweet_id":"708904589571952640"},{"url":"http:\/\/twitter.com\/analeoca66\/statuses\/708933511693123584","license":"gnip","rt":["JAMAOnc"],"citation_ids":[4892305],"posted_on":"2016-03-13T08:31:35+00:00","author":{"name":"Ana Le\u00f3n","image":"https:\/\/pbs.twimg.com\/profile_images\/709033083253686273\/Evb2uzJM_normal.jpg","id_on_source":"analeoca66","tweeter_id":"1494894864","geo":{"lt":null,"ln":null},"followers":89},"tweet_id":"708933511693123584"},{"url":"http:\/\/twitter.com\/weldeiry\/statuses\/709205684903141376","license":"gnip","rt":["JAMAOnc"],"citation_ids":[4892305],"posted_on":"2016-03-14T02:33:06+00:00","author":{"name":"Wafik El-Deiry MDPhD","url":"http:\/\/t.co\/QvllQmQTQT","image":"http:\/\/pbs.twimg.com\/profile_images\/581277124398485504\/ZRPMkbli_normal.jpg","description":"Translational Physician-Scientist, Deputy Director at Fox Chase Cancer Center, Journal Editor, Cancer Researcher, Entrepreneur","id_on_source":"weldeiry","tweeter_id":"14562968","followers":4573},"tweet_id":"709205684903141376"},{"url":"http:\/\/twitter.com\/JAMAOnc\/statuses\/708903238825693184","license":"gnip","citation_ids":[4892305],"posted_on":"2016-03-13T06:31:17+00:00","author":{"name":"JAMA Oncology","image":"https:\/\/pbs.twimg.com\/profile_images\/512275426798882816\/piK2tIt6_normal.png","id_on_source":"JAMAOnc","tweeter_id":"2811548749","geo":{"lt":null,"ln":null},"followers":11174},"tweet_id":"708903238825693184"}],"facebook":[{"title":"Familial Carcinoma of Unknown Primary","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=992234734167183&id=759822190741773","license":"public","citation_ids":[4892305],"posted_on":"2015-12-18T06:31:15+00:00","summary":"Approximately 3% to 5% of all human cancers manifest as carcinoma of unknown primary (CUP), which is the seventh most frequent histologically confirmed cancer and the fourth most common cancer-related cause of death in patients of both sexes.1 Currently, C","author":{"name":"JAMA Oncology","url":"https:\/\/www.facebook.com\/759822190741773","facebook_wall_name":"JAMA Oncology","image":"https:\/\/graph.facebook.com\/759822190741773\/picture","id_on_source":"759822190741773"}},{"title":"Familial Carcinoma of Unknown Primary","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1043042712419718&id=759822190741773","license":"public","citation_ids":[4892305],"posted_on":"2016-03-13T06:31:15+00:00","summary":"Approximately 3% to 5% of all human cancers manifest as carcinoma of unknown primary (CUP), which is the seventh most frequent histologically confirmed cancer and the fourth most common cancer-related cause of death in patients of both sexes.1 Currently, C","author":{"name":"JAMA Oncology","url":"https:\/\/www.facebook.com\/759822190741773","facebook_wall_name":"JAMA Oncology","image":"https:\/\/graph.facebook.com\/759822190741773\/picture","id_on_source":"759822190741773"}}],"googleplus":[{"url":"https:\/\/plus.google.com\/103101432872005382678\/posts\/hg9FXqvqEN3","license":"public","citation_ids":[4892305],"posted_on":"2015-12-18T06:31:18+00:00","summary":"Familial Carcinoma of Unknown Primary Approximately 3% to 5% of all human cancers manifest as carcinoma of unknown primary (CUP), which is the seventh most frequent histologically confirmed cancer and the fourth most common cancer-related cause of death in","author":{"name":"JAMA Oncology","url":"https:\/\/plus.google.com\/103101432872005382678","image":"https:\/\/lh6.googleusercontent.com\/-B1K88V9rDns\/AAAAAAAAAAI\/AAAAAAAAAD8\/9Wfo55R-k_w\/photo.jpg?sz=50","id_on_source":"103101432872005382678"}}]}}